Table 2.
The miRNA regulating activity levels in in vivo studies depending on the different enoxacin concentrations.
| miRNA | Dose | Effect | Expression Change: | Tissue | Ref. |
|---|---|---|---|---|---|
| [↑/↓] | Change-Fold | ||||
| miR-124 | 10 mg/kg 25 mg/kg |
↑ | ca. 4. ca. 6 |
rat frontal cortex | [66] |
| let-7a, miR-125a-5p | 10 mg/kg 25 mg/kg |
↑ | ca. 11. ca. 20 |
||
| miR-132 | 10 mg/kg 25 mg/kg |
↑ | ca. 19 (for both doses) |
||
| miR-30a-5p, miR-146b-5 | 15 mg/kg | ↑ | 1.5–2 | human orthotopic thyroid tumor from Cal62-luc mouse | [39] |
| mIR-100-5p, miR-30-3p, miR-204-5 | 15 mg/kg | ↑ | 2–2.5 | human orthotopic thyroid tumor from Cal62-luc mouse | [39] |
| miR-16, miR-18a*, miR-21, miR-26a, miR-29b, miR-29c, miR-31, miR-101, miR-193a | 10 mg/kg | ↑ | 1.5–2 | tumor from HCT-116 mouse xenograft | [36] |
| miR-16, miR-29c, miR-31, miR-101, miR-181a | 10 mg/kg | ↑ | 1.5–2 | tumor from RKO mouse xenograft | [36] |
| miR-128, miR-212 | 10 mg/kg | ↑ | 2–2.5 | tumor from HCT-116 mouse xenograft | [36] |
| miR-18a*, miR-21, miR-26a, miR-29b, miR-30a, miR-128 | 10 mg/kg | ↑ | 2–2.5 | tumor from RKO mouse xenograft | [36] |
| let-7b, miR-7, miR-143, miR-181b, miR-125b | 10 mg/kg | ↑ | 2.5–3 | tumor from HCT-116 mouse xenograft | [36] |
| let-7a, miR-7, miR-122, miR-125a, miR-125b, miR-126, miR-181b, miR-193a, miR-193b, miR-205, miR-212 | 10 mg/kg | ↑ | 2.5–3 | tumor from RKO mouse xenograft | [36] |
| let-7a, miR-30a, miR-122, miR-126 | 10 mg/kg | ↑ | 3–3.5 | tumor from HCT-116 mouse xenograft | [36] |
| miR-143 | 10 mg/kg | ↑ | 3–3.5 | tumor from RKO mouse xenograft | [36] |
| miR-125a, miR-181a, miR-193b | 10 mg/kg | ↑ | 3.5–4 | tumor from HCT-116 mouse xenograft | [36] |
| let-7b | 10 mg/kg | ↑ | 4.5–5 | tumor from RKO mouse xenograft | [36] |
| miR-205 | 10 mg/kg | ↑ | 4.5–5 | tumor from HCT-116 mouse xenograft | [36] |